ICARE Eye Hospital and Post Graduate Institute is committed to excellence in Academics and Research. We are a part of different multi-center studies.
Ongoing Studies
Indication: UME
Protocol No. : GR44278
Name of PI: Dr Shahana Mazumdar
Indication: DME
Protocol No. : DX219
Name of PI: Dr Shahana Mazumdar
Indication: Pterygium
Protocol No. : CBT-CS301
Name of PI: Dr. Uma Sridhar
Completed/Terminated
Protocol: Wet ARMD-Razumab (Intas Biopharmaceuticals Pvt. Ltd.)
Protocol No. : 045-15
Name of PI: Dr Neha Goel
CTRI No. : CTRI/2016/03/006739
Protocol: Retinal Vein Occlusion (RVO)-Ranibizumab(Novartis Healthcare Ltd.)
Protocol No.: CRFB002EIN02- UNVEIL-RVO
Name of PI: Dr Neha Goel
CTRI No. : CTRI/2015/07/005985
Protocol: Posterior Uveitis (Fluocinolone Acetonide Intravitreal Insert)
Protocol No. : PSV-FAI-005
Name of PI: Dr Shahana Mazumdar
CTRI No. : CTRI/2014/12/005337
Protocol: A Phase 3, Randomized, Masked, Controlled Clinical Trial to study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the treatment of subjects with Macular Edema associated with Non-Infectious Uveitis.
Protocol No. CLS1001-301
Name of PI: Dr. Neha Goel
CTRI No. : CTRI/2016/09/007269
Protocol: A Phase 2/3, Randomized, Double-Masked, Sham-controlled Trial of QPI-1007 delivered by single or multi-dose Intravitreal Injection(s) to subjects with Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Protocol No: QRK-207
Name of PI: Dr. Shahana Mazumdar
CTRI No. : CTRI/2015/12/006402
Protocol: Multi-Center, Non-Interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema associated with Non-infectious Uveitis..
Protocol No. CLS1001-303 (Extension Study of CLS1001-301)
Name of PI: Dr. Neha Goel
Protocol: Prospective Feasibility study to evaluate safety and efficacy of Ultrasound Ciliary Plasty in refractory Glaucoma Patients
Protocol No.: CS#17-I-04 (Eye Tech Care)
Name of PI: Dr. Reena Choudhry
CTRI No. : Applied for registration
Protocol: A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Protocol No. : SHP640 -301
Name of PI: Dr. Uma Sridhar
Protocol: Non-infectious Posterior Uveitis (SAKURA Study)
Protocol No. : 32-007 (DE-109)
Name of PI: Dr. Shahana Mazumdar
Protocol: A Phase IV Controlled Clinical Trial Study to Compare the Efficacy and Safety of twice a day CYCLOSPORINE (0.05%) Ophthalmic Emulsion against twice a day RESTASIS® in Subjects with Moderate to Severe KeratoconjunctivitisSicca.
Protocol No. : NIBP-014-001
Name of PI: Dr. Uma Sridhar
Sponsor: New India Biopharma Pvt Ltd(NIBP)
Protocol: Clinical Evaluation of Systane® Balance on Corneal Staining in Indian Subjects with Dry Eye.
Protocol No. : EXJ821-P001 (C-13-039)
Name of PI: Dr. Uma Sridhar
Protocol: A Phase IIIb, Multinational, Multicenter, Double-Masked Study. Assessing the long -term safety of PRN Intravitreal Injections of DE-109 in Subjects with Non-Infectious Uveitis of the Posterior Segment of the eye who have participated in the SAKURA Development Program.
Protocol No. : 32-009 (Extension Study of 32-007 protocol)
Name of PI: Dr. Dr. Shahana Mazumdar
Protocol: Non-infectious Posterior Uveitis (SAKURA Study)
Protocol No.: 32-007 (DE-109)
Name of PI: Dr. Shahana Mazumdar
Protocol: A Phase IV Controlled Clinical Trial Study to Compare the Efficacy and Safety of twice a day CYCLOSPORINE (0.05%) Ophthalmic Emulsion against twice a day RESTASIS® in Subjects with Moderate to Severe KeratoconjunctivitisSicca.
Protocol No. NIBP-014-001
Name of PI: Dr. Uma Sridhar
Protocol: Clinical Evaluation of Systane® Balance on Corneal Staining in Indian Subjects with Dry Eye.
Protocol No. EXJ821-P001 (C-13-039)
Name of PI: Dr. Uma Sridhar
Protocol: A Phase IIIb, Multinational, Multicenter, Double-Masked Study. Assessing the long -term safety of PRN Intravitreal Injections of DE-109 in Subjects with Non-Infectious Uveitis of the Posterior Segment of the eye who have participated in the SAKURA Development Program.
Protocol No.: 32-009 (Extension Study of 32-007 protocol)
Name of PI: Dr. Dr. Shahana Mazumdar